Research Overview of DES (1-3) IGF-1
DES (1-3) IGF-1 is a modified insulin-like growth factor peptide that has undergone truncation to remove the first three amino acids from the N-terminus. This structural modification significantly alters the peptide’s binding properties and biological activity profile, making it an invaluable compound for cellular research and biochemical investigations. Researchers at Stroid UK Shop frequently examine this peptide’s unique characteristics in controlled experimental settings.
The DES variant demonstrates reduced affinity for IGF binding proteins compared to full-length IGF-1, allowing researchers to study direct cellular interactions without interference from binding protein complexes. This property makes it particularly useful for investigating immediate cellular responses and receptor activation mechanisms in laboratory environments.
Laboratory Research Applications
Research teams utilise DES (1-3) IGF-1 to investigate cellular proliferation mechanisms, protein synthesis pathways, and metabolic regulatory processes. The compound’s modified structure enables researchers to examine specific receptor interactions that would otherwise be masked by binding proteins in full-length IGF-1 studies. Scientists working with research peptides often incorporate this variant into comparative studies alongside other growth factor analogues.
Cell culture experiments frequently employ this peptide to evaluate anabolic signalling cascades and their downstream effects on cellular metabolism. Research applications extend to studies examining muscle cell development, tissue repair mechanisms, and growth hormone pathway interactions. Many laboratories combine DES (1-3) IGF-1 research with investigations into selective androgen receptor modulators to understand synergistic cellular responses.
Product Specifications
| Purity | ≥98% (HPLC verified) |
|---|---|
| Molecular Weight | Verify with supplier |
| Storage | -20°C, protected from light |
| Solubility | Sterile water, pH 3-4 |
| Quantity | 1mg per vial |
| Manufacturer | St Biotechnology Co |
Each vial contains lyophilised powder requiring reconstitution with appropriate solvent for research applications. Researchers studying similar compounds often examine protocols available through peptide research categories for optimal handling procedures.
Research Compliance Statement
DES (1-3) IGF-1 is manufactured exclusively for in-vitro research purposes and laboratory investigations. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with institutional guidelines and regulatory requirements when conducting studies with this peptide compound.
